NVTIA™ 5-HTP–L-Theanine–GABA Sleep Rhythm Support System: Ratio Optimization, Gastrointestinal Tolerability, and Evidence from Human Studies and Preclinical Evaluation
International Journal of Agriculture and Food Sciences Research · 29.04.2026 · 4 (1) · 53-60
DOI: 10.62051/ijafsr.v4n1.04 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Agriculture and Food Sciences Research, online erschienen am 29.04.2026. Verfasst von Jabar Yassine und 2 weiteren Autor:innen. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Nutritional sleep-support strategies often underperform because they address only one pathway or do not balance efficacy with tolerability. We examined an NVTIA™ 5-HTP–L-theanine–GABA ternary system and aligned its disclosed formulation and mouse data with current published human evidence on the same three axes.
Methods
We summarized the disclosed composition window, excipient module, process parameters, and preclinical sleep-evaluation results, and screened recent peer-reviewed human trials and evidence syntheses available through March 2026.
Results
Published human evidence supports biological plausibility and modest clinical benefit for the individual components. A 12-week randomized controlled trial in older adults found that 100 mg/day 5-HTP improved certain sleep-quality components, particularly in poor sleepers. A 2025 meta-analysis of L-theanine trials reported significant improvements in subjective sleep-onset latency, daytime dysfunction, and overall subjective sleep quality. A 4-week double-blind trial of 300 mg/day oral GABA showed reduced sleep latency and improved sleep efficacy, although systematic-review evidence for oral GABA remains limited and heterogeneous. Against this clinical background, the disclosed ternary formulations showed dose-responsive preclinical performance.
Conclusions
The NVTIA™ platform is best interpreted as a coordinated formulation-engineering system in which precursor support, relaxation support, inhibitory-neurotransmission support, gastrointestinal-tolerability excipients, and process control are aligned. These results justify further controlled human validation of optimized ternary ratios.
Zitieren
APA
Yassine, J., Semenza, G. L., & Collins, L. (2026). NVTIA™ 5-HTP–L-Theanine–GABA Sleep Rhythm Support System: Ratio Optimization, Gastrointestinal Tolerability, and Evidence from Human Studies and Preclinical Evaluation. International Journal of Agriculture and Food Sciences Research, 4(1), 53-60. https://doi.org/10.62051/ijafsr.v4n1.04
Vancouver
Yassine J, Semenza GL, Collins L. NVTIA™ 5-HTP–L-Theanine–GABA Sleep Rhythm Support System: Ratio Optimization, Gastrointestinal Tolerability, and Evidence from Human Studies and Preclinical Evaluation. International Journal of Agriculture and Food Sciences Research. 2026;4(1):53-60. doi:10.62051/ijafsr.v4n1.04
BibTeX
@article{Yassine2026,
author = {Yassine, Jabar and Semenza, Gregg L. and Collins, Lily},
title = {NVTIA™ 5-HTP–L-Theanine–GABA Sleep Rhythm Support System: Ratio Optimization, Gastrointestinal Tolerability, and Evidence from Human Studies and Preclinical Evaluation},
journal = {International Journal of Agriculture and Food Sciences Research},
year = {2026},
volume = {4},
number = {1},
pages = {53--60},
doi = {10.62051/ijafsr.v4n1.04}
}
EUVIMED